Global Eculizumab Market Growth 2026-2032

January 2026 | 82 pages | ID: G192B5FE0212EN
LP Information

Abstracts

The global Eculizumab market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

Eculizumab is a monoclonal antibody that inhibits complement protein C5, blocking the formation of the membrane attack complex (MAC) and preventing immune-mediated cell destruction. It is primarily used to treat rare diseases such as paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS), as well as generalized myasthenia gravis (gMG) and neuromyelitis optica spectrum disorder (NMOSD).

United States market for Eculizumab is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Eculizumab is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Eculizumab is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Eculizumab players cover Alexion Pharmaceuticals, Amgen, Samsung Bioepis, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LP Information, Inc. (LPI) ' newest research report, the ?Eculizumab Industry Forecast? looks at past sales and reviews total world Eculizumab sales in 2025, providing a comprehensive analysis by region and market sector of projected Eculizumab sales for 2026 through 2032. With Eculizumab sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Eculizumab industry.

This Insight Report provides a comprehensive analysis of the global Eculizumab landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Eculizumab portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Eculizumab market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Eculizumab and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Eculizumab.

This report presents a comprehensive overview, market shares, and growth opportunities of Eculizumab market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Original Drug
• Biosimilar

Segmentation by Application:

• PNH
• aHUS
• gMG
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Alexion Pharmaceuticals
• Amgen
• Samsung Bioepis

Key Questions Addressed in this Report
What is the 10-year outlook for the global Eculizumab market?
What factors are driving Eculizumab market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Eculizumab market opportunities vary by end market size?
How does Eculizumab break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Eculizumab Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Eculizumab by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Eculizumab by Country/Region, 2021, 2025 & 2032
2.2 Eculizumab Segment by Type
  2.2.1 Original Drug
  2.2.2 Biosimilar
  2.2.3 Eculizumab Sales by Type
    2.2.3.1 Global Eculizumab Sales Market Share by Type (2021-2026)
    2.2.3.2 Global Eculizumab Revenue and Market Share by Type (2021-2026)
    2.2.3.3 Global Eculizumab Sale Price by Type (2021-2026)
2.3 Eculizumab Segment by Application
  2.3.1 PNH
  2.3.2 aHUS
  2.3.3 gMG
  2.3.4 Others
  2.3.5 Eculizumab Sales by Application
    2.3.5.1 Global Eculizumab Sale Market Share by Application (2021-2026)
    2.3.5.2 Global Eculizumab Revenue and Market Share by Application (2021-2026)
    2.3.5.3 Global Eculizumab Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global Eculizumab Breakdown Data by Company
  3.1.1 Global Eculizumab Annual Sales by Company (2021-2026)
  3.1.2 Global Eculizumab Sales Market Share by Company (2021-2026)
3.2 Global Eculizumab Annual Revenue by Company (2021-2026)
  3.2.1 Global Eculizumab Revenue by Company (2021-2026)
  3.2.2 Global Eculizumab Revenue Market Share by Company (2021-2026)
3.3 Global Eculizumab Sale Price by Company
3.4 Key Manufacturers Eculizumab Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Eculizumab Product Location Distribution
  3.4.2 Players Eculizumab Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR ECULIZUMAB BY GEOGRAPHIC REGION

4.1 World Historic Eculizumab Market Size by Geographic Region (2021-2026)
  4.1.1 Global Eculizumab Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Eculizumab Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Eculizumab Market Size by Country/Region (2021-2026)
  4.2.1 Global Eculizumab Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Eculizumab Annual Revenue by Country/Region (2021-2026)
4.3 Americas Eculizumab Sales Growth
4.4 APAC Eculizumab Sales Growth
4.5 Europe Eculizumab Sales Growth
4.6 Middle East & Africa Eculizumab Sales Growth

5 AMERICAS

5.1 Americas Eculizumab Sales by Country
  5.1.1 Americas Eculizumab Sales by Country (2021-2026)
  5.1.2 Americas Eculizumab Revenue by Country (2021-2026)
5.2 Americas Eculizumab Sales by Type (2021-2026)
5.3 Americas Eculizumab Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Eculizumab Sales by Region
  6.1.1 APAC Eculizumab Sales by Region (2021-2026)
  6.1.2 APAC Eculizumab Revenue by Region (2021-2026)
6.2 APAC Eculizumab Sales by Type (2021-2026)
6.3 APAC Eculizumab Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Eculizumab by Country
  7.1.1 Europe Eculizumab Sales by Country (2021-2026)
  7.1.2 Europe Eculizumab Revenue by Country (2021-2026)
7.2 Europe Eculizumab Sales by Type (2021-2026)
7.3 Europe Eculizumab Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Eculizumab by Country
  8.1.1 Middle East & Africa Eculizumab Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Eculizumab Revenue by Country (2021-2026)
8.2 Middle East & Africa Eculizumab Sales by Type (2021-2026)
8.3 Middle East & Africa Eculizumab Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Eculizumab
10.3 Manufacturing Process Analysis of Eculizumab
10.4 Industry Chain Structure of Eculizumab

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Eculizumab Distributors
11.3 Eculizumab Customer

12 WORLD FORECAST REVIEW FOR ECULIZUMAB BY GEOGRAPHIC REGION

12.1 Global Eculizumab Market Size Forecast by Region
  12.1.1 Global Eculizumab Forecast by Region (2027-2032)
  12.1.2 Global Eculizumab Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Eculizumab Forecast by Type (2027-2032)
12.7 Global Eculizumab Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 Alexion Pharmaceuticals
  13.1.1 Alexion Pharmaceuticals Company Information
  13.1.2 Alexion Pharmaceuticals Eculizumab Product Portfolios and Specifications
  13.1.3 Alexion Pharmaceuticals Eculizumab Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Alexion Pharmaceuticals Main Business Overview
  13.1.5 Alexion Pharmaceuticals Latest Developments
13.2 Amgen
  13.2.1 Amgen Company Information
  13.2.2 Amgen Eculizumab Product Portfolios and Specifications
  13.2.3 Amgen Eculizumab Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 Amgen Main Business Overview
  13.2.5 Amgen Latest Developments
13.3 Samsung Bioepis
  13.3.1 Samsung Bioepis Company Information
  13.3.2 Samsung Bioepis Eculizumab Product Portfolios and Specifications
  13.3.3 Samsung Bioepis Eculizumab Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 Samsung Bioepis Main Business Overview
  13.3.5 Samsung Bioepis Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Eculizumab Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Eculizumab Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Original Drug
Table 4. Major Players of Biosimilar
Table 5. Global Eculizumab Sales by Type (2021-2026) & (K Units)
Table 6. Global Eculizumab Sales Market Share by Type (2021-2026)
Table 7. Global Eculizumab Revenue by Type (2021-2026) & ($ million)
Table 8. Global Eculizumab Revenue Market Share by Type (2021-2026)
Table 9. Global Eculizumab Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Eculizumab Sale by Application (2021-2026) & (K Units)
Table 11. Global Eculizumab Sale Market Share by Application (2021-2026)
Table 12. Global Eculizumab Revenue by Application (2021-2026) & ($ million)
Table 13. Global Eculizumab Revenue Market Share by Application (2021-2026)
Table 14. Global Eculizumab Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Eculizumab Sales by Company (2021-2026) & (K Units)
Table 16. Global Eculizumab Sales Market Share by Company (2021-2026)
Table 17. Global Eculizumab Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Eculizumab Revenue Market Share by Company (2021-2026)
Table 19. Global Eculizumab Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Eculizumab Producing Area Distribution and Sales Area
Table 21. Players Eculizumab Products Offered
Table 22. Eculizumab Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Eculizumab Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Eculizumab Sales Market Share Geographic Region (2021-2026)
Table 27. Global Eculizumab Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Eculizumab Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Eculizumab Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Eculizumab Sales Market Share by Country/Region (2021-2026)
Table 31. Global Eculizumab Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Eculizumab Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Eculizumab Sales by Country (2021-2026) & (K Units)
Table 34. Americas Eculizumab Sales Market Share by Country (2021-2026)
Table 35. Americas Eculizumab Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Eculizumab Sales by Type (2021-2026) & (K Units)
Table 37. Americas Eculizumab Sales by Application (2021-2026) & (K Units)
Table 38. APAC Eculizumab Sales by Region (2021-2026) & (K Units)
Table 39. APAC Eculizumab Sales Market Share by Region (2021-2026)
Table 40. APAC Eculizumab Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Eculizumab Sales by Type (2021-2026) & (K Units)
Table 42. APAC Eculizumab Sales by Application (2021-2026) & (K Units)
Table 43. Europe Eculizumab Sales by Country (2021-2026) & (K Units)
Table 44. Europe Eculizumab Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Eculizumab Sales by Type (2021-2026) & (K Units)
Table 46. Europe Eculizumab Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Eculizumab Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Eculizumab Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Eculizumab Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Eculizumab Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Eculizumab
Table 52. Key Market Challenges & Risks of Eculizumab
Table 53. Key Industry Trends of Eculizumab
Table 54. Eculizumab Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Eculizumab Distributors List
Table 57. Eculizumab Customer List
Table 58. Global Eculizumab Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Eculizumab Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Eculizumab Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Eculizumab Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Eculizumab Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Eculizumab Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Eculizumab Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Eculizumab Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Eculizumab Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Eculizumab Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Eculizumab Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Eculizumab Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Eculizumab Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Eculizumab Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Alexion Pharmaceuticals Basic Information, Eculizumab Manufacturing Base, Sales Area and Its Competitors
Table 73. Alexion Pharmaceuticals Eculizumab Product Portfolios and Specifications
Table 74. Alexion Pharmaceuticals Eculizumab Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Alexion Pharmaceuticals Main Business
Table 76. Alexion Pharmaceuticals Latest Developments
Table 77. Amgen Basic Information, Eculizumab Manufacturing Base, Sales Area and Its Competitors
Table 78. Amgen Eculizumab Product Portfolios and Specifications
Table 79. Amgen Eculizumab Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Amgen Main Business
Table 81. Amgen Latest Developments
Table 82. Samsung Bioepis Basic Information, Eculizumab Manufacturing Base, Sales Area and Its Competitors
Table 83. Samsung Bioepis Eculizumab Product Portfolios and Specifications
Table 84. Samsung Bioepis Eculizumab Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Samsung Bioepis Main Business
Table 86. Samsung Bioepis Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Eculizumab
Figure 2. Eculizumab Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Eculizumab Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Eculizumab Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Eculizumab Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Eculizumab Sales Market Share by Country/Region (2025)
Figure 10. Eculizumab Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Original Drug
Figure 12. Product Picture of Biosimilar
Figure 13. Global Eculizumab Sales Market Share by Type in 2026
Figure 14. Global Eculizumab Revenue Market Share by Type (2021-2026)
Figure 15. Eculizumab Consumed in PNH
Figure 16. Global Eculizumab Market: PNH (2021-2026) & (K Units)
Figure 17. Eculizumab Consumed in aHUS
Figure 18. Global Eculizumab Market: aHUS (2021-2026) & (K Units)
Figure 19. Eculizumab Consumed in gMG
Figure 20. Global Eculizumab Market: gMG (2021-2026) & (K Units)
Figure 21. Eculizumab Consumed in Others
Figure 22. Global Eculizumab Market: Others (2021-2026) & (K Units)
Figure 23. Global Eculizumab Sale Market Share by Application (2025)
Figure 24. Global Eculizumab Revenue Market Share by Application in 2026
Figure 25. Eculizumab Sales by Company in 2026 (K Units)
Figure 26. Global Eculizumab Sales Market Share by Company in 2026
Figure 27. Eculizumab Revenue by Company in 2026 ($ millions)
Figure 28. Global Eculizumab Revenue Market Share by Company in 2026
Figure 29. Global Eculizumab Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Eculizumab Revenue Market Share by Geographic Region in 2026
Figure 31. Americas Eculizumab Sales 2021-2026 (K Units)
Figure 32. Americas Eculizumab Revenue 2021-2026 ($ millions)
Figure 33. APAC Eculizumab Sales 2021-2026 (K Units)
Figure 34. APAC Eculizumab Revenue 2021-2026 ($ millions)
Figure 35. Europe Eculizumab Sales 2021-2026 (K Units)
Figure 36. Europe Eculizumab Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Eculizumab Sales 2021-2026 (K Units)
Figure 38. Middle East & Africa Eculizumab Revenue 2021-2026 ($ millions)
Figure 39. Americas Eculizumab Sales Market Share by Country in 2026
Figure 40. Americas Eculizumab Revenue Market Share by Country (2021-2026)
Figure 41. Americas Eculizumab Sales Market Share by Type (2021-2026)
Figure 42. Americas Eculizumab Sales Market Share by Application (2021-2026)
Figure 43. United States Eculizumab Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Eculizumab Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Eculizumab Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Eculizumab Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Eculizumab Sales Market Share by Region in 2026
Figure 48. APAC Eculizumab Revenue Market Share by Region (2021-2026)
Figure 49. APAC Eculizumab Sales Market Share by Type (2021-2026)
Figure 50. APAC Eculizumab Sales Market Share by Application (2021-2026)
Figure 51. China Eculizumab Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Eculizumab Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Eculizumab Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Eculizumab Revenue Growth 2021-2026 ($ millions)
Figure 55. India Eculizumab Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Eculizumab Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Eculizumab Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Eculizumab Sales Market Share by Country in 2026
Figure 59. Europe Eculizumab Revenue Market Share by Country (2021-2026)
Figure 60. Europe Eculizumab Sales Market Share by Type (2021-2026)
Figure 61. Europe Eculizumab Sales Market Share by Application (2021-2026)
Figure 62. Germany Eculizumab Revenue Growth 2021-2026 ($ millions)
Figure 63. France Eculizumab Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Eculizumab Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Eculizumab Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Eculizumab Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Eculizumab Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Eculizumab Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Eculizumab Sales Market Share by Application (2021-2026)
Figure 70. Egypt Eculizumab Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Eculizumab Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Eculizumab Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Eculizumab Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Eculizumab Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Eculizumab in 2026
Figure 76. Manufacturing Process Analysis of Eculizumab
Figure 77. Industry Chain Structure of Eculizumab
Figure 78. Channels of Distribution
Figure 79. Global Eculizumab Sales Market Forecast by Region (2027-2032)
Figure 80. Global Eculizumab Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Eculizumab Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Eculizumab Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Eculizumab Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Eculizumab Revenue Market Share Forecast by Application (2027-2032)